/SPEC.ST
SPEC.ST Stock - SpectraCure AB (publ)
Healthcare|Medical - DevicesSTO
$0.16-5.36%
$0.01 (-5.36%) • Dec 23
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.17
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SPEC.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.16 – $0.16
TARGET (TP)$0.18
STOP LOSS$0.15
RISK/REWARD1:2.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.50
52W High$3.60
52W Low$0.14
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $318,000 | $539,000 | N/A | $1,211 |
| Gross Profit | $9.77M | $-9,223,000 | $3.58M | $1.39M | $2.35M |
| Gross Margin | N/A | -2900.3% | 665.1% | N/A | 194154.5% |
| Operating Income | $-24,485,000 | $-21,351,000 | $-26,978,000 | $-24,417,000 | $-16,465,000 |
| Net Income | $-23,004,000 | $-20,441,000 | $-25,326,000 | $-23,341,000 | $-15,407,000 |
| Net Margin | N/A | -6428.0% | -4698.7% | N/A | -1272254.3% |
| EPS | $-0.24 | $-0.21 | $-0.26 | $-0.24 | $-0.17 |
Company Overview
SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SPEC.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.05
Q4 2024
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | $-0.05 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.06 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.06 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.05 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.06 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.05 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.06 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.06 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.07 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.06 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.07 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.06 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.07 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.06 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.07 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.05 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.04 | — | — |
Q4 2020 | Nov 12, 2020 | — | $-0.05 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.02 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.04 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SPEC.ST
What is SPEC.ST's current stock price?
SpectraCure AB (publ) (SPEC.ST) is currently trading at $0.16 per share. The stock has moved -5.36% today.
What is the analyst price target for SPEC.ST?
No analyst price targets are currently available for this stock.
What sector is SpectraCure AB (publ) in?
SpectraCure AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.
What is SPEC.ST's market cap?
SpectraCure AB (publ) has a market capitalization of $0.07 billion, making it a small-cap company.
Does SPEC.ST pay dividends?
No, SpectraCure AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATORX.ST
Alligator Bioscience AB (publ)
$0.34
Mkt Cap: $0.0B
EPIS-B.ST
Episurf Medical AB (publ)
$0.03
Mkt Cap: $0.0B
HEART.ST
Scandinavian Real Heart AB (Publ)
$14.00
Mkt Cap: $0.1B
ICO.ST
Iconovo AB (publ)
$1.14
Mkt Cap: $0.1B
IDLDX.ST
IDL Diagnostics AB (publ)
$0.35
Mkt Cap: $0.1B
LXB.ST
Luxbright AB (publ)
$0.45
Mkt Cap: $0.1B
SDOS.ST
ScandiDos AB (publ)
$1.15
Mkt Cap: $0.1B
SIMRIS-B.ST
Simris Alg AB (publ)
$0.05
Mkt Cap: $0.0B
SPAGO.ST
Spago Nanomedical AB (publ)
$0.10
Mkt Cap: $0.0B
SPRINT.ST
Sprint Bioscience AB (publ)
$1.45
Mkt Cap: $0.2B
Explore stocks similar to SPEC.ST for comparison